China issues first commercial brain chip license

China has granted the world's first commercial license for brain chip implantation, approving the NEO device developed by NeuraMatrix in collaboration with Tsinghua University. This device allows patients to control devices through thought, achieving results such as moving their hands and controlling computer cursors. This decision is part of China's strategy to become a global leader in brain-computer interface technologies by 2030, with streamlined approval processes and the emergence of government-funded startups. Despite China's progress, the United States still relies on research programs and has not yet granted full commercial approval for brain chip technologies.

Size: 120%Text Size

Notice: This Is an AI-Generated Summary

Display The Full Article